Loading
The software of oncology
136 products from 117 vendors, in six categories: the oncology record and the chemotherapy prescribing layer, radiotherapy planning and quality assurance, the pathology and radiology platforms, algorithms cleared to read a scan or a slide, genomics and interpretation, trial matching and registries, and case review. 102 rows are backed by something outside the company that sells them; 34 are the company describing itself, and are marked as such in every view. The open-source projects the field runs on are mapped separately, in full, on /open-source/.
136 products102 independently sourced, 34 on the company's own account188 FDA records across 57 products62 named in the literature79 sold by a company or institution in OnCo17 looked for and not recorded
What this page covers, and what it will not do
Between a symptom and a treatment there is a chain of software, and almost none of it is open. A referral lands in an oncology record; a regimen is ordered through a prescribing layer that will refuse a dose it does not like; a scan is read on a reading platform, sometimes with a cleared algorithm marking it first; a slide is scanned and read on a pathology platform; a radiotherapy plan is optimised in a planning system and checked by quality assurance software; a tumour is sequenced and the result is turned into options by an interpretation platform; a trial is found through something running against the public registry. Each of those changes what a patient gets, and each is on this page.
Open source stays where it is. The 379 open-source projects in oncology have their own map, with licence, openness and last commit read from each repository: /open-source/. This page is the rest of the field. The one thing it takes back from that map is the set of research tools excluded there by design for being commercial, licensed or free but closed, from Sentieon to CIBERSORTx to CanRisk: they are here instead, with their evidence attached rather than only a line in a skip list.
What this page will not do is repeat a company's performance claim as though it were a finding. A vendor's own site is enough to establish that a product exists, what it says it does and where it lives. It is not enough for anything about accuracy, adoption, outcomes or regulatory status. Read the next card before reading the table.
How a row is sourced
Every row is built the same way. The company's own page is fetched, and its own description of the product is copied into the row verbatim, in the column marked the company's words. Then three checks run for a source outside the company, and each one has to name the product before it counts:
- A regulator. The FDA device databases, read through openFDA: every clearance, De Novo grant, approval and supplement returned by the query, with its number, the device name, the applicant and the decision date as the database words them. 57 products carry at least one, 188 records in all.
- The literature. Europe PMC, with every hit checked to name the product in its title or abstract. Preprints are recorded as preprints and are not called peer reviewed. 62 products carry at least one paper.
- A public body's own list. A framework, a procurement listing, a guideline or a registry page, fetched and checked for the product's name.
A row with at least one of those is independently sourced. A row with none of them is the company's own account, and the page says so in the row, in the filter and in the count at the top. That is not a lesser kind of record: it is an honest one. 34 of 136 rows are in that state today, and naming them is the point.
By category
By what is behind the row
By kind of source
By what it does
- Oncology electronic record 7
- Chemotherapy prescribing 5
- Radiotherapy planning 14
- Radiotherapy QA and dosimetry 5
- Patient positioning and monitoring 2
- Pathology platform 6
- Pathology AI 8
- Radiology platform 4
- Radiology AI 17
- Endoscopy and dermatology AI 5
- Sequencing and variant calling 3
- Variant interpretation and reporting 11
- Comprehensive genomic profiling 7
- Trial registry 4
- Trial matching 6
- Trial conduct software 7
- Cancer registry software 2
- Real-world data platform 4
- Case review and second opinion 9
- Patient-reported outcomes 2
- Risk and decision tools 2
- Research analysis tool 6
136 products
| The company's words | Technologies | Link | |||||||
|---|---|---|---|---|---|---|---|---|---|
GI Genius Medtronic · first outside trace 2022 A module that watches the colonoscopy video in real time and boxes possible polyps, the first computer-aided detection device of its kind authorised in the United States. | Medtronic | K261369, K241887, K233964 | none | AI polyp detection in colonoscopy | api.fda.gov | ||||
Transpara ScreenPoint Medical · first outside trace 2019 A mammography reading algorithm used in screening programmes, scoring each examination and marking suspicious findings for the reader. | ScreenPoint Medical | K260898, K241831, K232096 | Transpara Breast AI by ScreenPoint Medical offers earlier detection and enhanced workflow when reading 3D and… | AI in radiology | screenpoint-medical.com | ||||
ClearRead CT Riverain Technologies · first outside trace 2013 Software that suppresses vessels on chest CT so nodules stand out, with a detection algorithm on top. | K242188, K221612, K213566 | Riverain Technologies delivers AI-powered ClearRead solutions for chest CT and X-ray. Improve accuracy, reduc… | AI in radiology | riveraintech.com | |||||
FoundationOne CDx Foundation Medicine (Roche) · first outside trace 2021 A comprehensive genomic profiling test and the report software around it, approved as a companion diagnostic for a long and growing list of drugs. | Foundation Medicine | P170019/S064, P170019/S057, P170019/S065 | Learn about FoundationOne CDx, an FDA-approved companion diagnostic for all solid tumors that analyzes 300+ g… | Comprehensive genomic profiling, Cancer variant knowledgebases and molecular tumour boards | foundationmedicine.com | ||||
Guardant360 CDx Guardant Health · first outside trace 2020 A blood-based genomic profiling test with the reporting and companion-diagnostic claims that let a result choose a drug without a tissue biopsy. | Guardant Health | P200010/S024, P200010/S032, P200010/S030 | Guardant Health is a leading precision medicine company focused on transforming patient care and conquering c… | Comprehensive genomic profiling | guardanthealth.com | ||||
AlignRT Vision RT · first outside trace 2019 Surface-guided radiotherapy: cameras watch the skin surface and hold the beam if the patient moves, which is how breath-hold breast treatment is delivered without tattoos. | Vision RT | K253012, K243301, K233622 | Vision RT is the inventor of Surface Guided Radiation Therapy (SGRT) and produces a range of innovative radio… | In-room imaging for radiotherapy | visionrt.com | ||||
ProFound AI iCAD (RadNet) · first outside trace 2019 Detection and density software for digital breast tomosynthesis and mammography, marking lesions and giving a case score. | iCAD | K240417, K203822, K191994 | Explore iCAD's ProFound AI solutions – find breast cancer earlier, with unmatched accuracy, 2x clinical perfo… | AI in radiology | icadmed.com | ||||
RayStation RaySearch Laboratories · first outside trace 2018 A treatment planning system for photons, protons and ions, with deep-learning segmentation and planning built in and a large physics literature behind it. | RaySearch Laboratories | K252109, K240398, K222312 | RayStation is the comprehensive treatment planning system for radiation therapy. RayStation can help revoluti… | Radiotherapy treatment planning and QA software, AI auto-contouring and adaptive planning | raysearchlabs.com | ||||
Monaco Elekta · first outside trace 2016 Elekta's treatment planning system, with a Monte Carlo dose engine and the planning side of its MR-guided systems. | Elekta | K252002, K223233, K213787 | Elekta ONE Planning | Oncology Software | Elekta | Radiotherapy treatment planning and QA software | elekta.com | ||||
Delta4 ScandiDos · first outside trace 2009 A measuring phantom and its software for verifying that a delivered plan matches the planned dose, and a version that checks it without a phantom. | K223234, K183606, K151426 | Start Page | Radiotherapy treatment planning and QA software | scandidos.com | |||||
Lunit INSIGHT Lunit · first outside trace 2023 A family of reading algorithms sold into screening and diagnostic imaging: mammography, tomosynthesis and chest radiographs, each cleared separately. | Lunit | K260320, K253796, K242652 | Advance breast cancer detection with our AI mammography reading solution. Boost accuracy, save time, and impr… | AI in radiology | lunit.io | ||||
qXR Qure.ai · first outside trace 2023 A family of chest radiograph and CT algorithms that flag lung nodules and other findings, deployed in screening and case-finding programmes in several countries. | K251934, K251610, K240740 | Qure ai is on a mission to provide accessible, affordable, & timely assistance to healthcare professionals | AI in radiology | qure.ai | |||||
Paige Prostate Paige AI · first outside trace 2020 An algorithm that flags areas suspicious for prostate cancer on a scanned biopsy slide, the first such pathology algorithm authorised in the United States. | Paige AI | K241273, DEN200080, K201005 | Paige.ai | AI scoring of biomarkers and grade on pathology slides, Pathology & radiology foundation models | paige.ai | ||||
Caris Molecular Intelligence and MI Cancer Seek Caris Life Sciences · first outside trace 2018 Caris's approved whole-exome and whole-transcriptome profiling test, with the reporting layer that turns it into treatment options. | Caris Life Sciences | P240010/S010, P240010/S009, P240010/S005 | Caris fulfills the promise of precision oncology through advanced laboratory testing, including tumor profili… | Comprehensive genomic profiling, RNA sequencing & expression profiling | carislifesciences.com | ||||
BriefCase Aidoc · first outside trace 2026 Aidoc's family of triage algorithms that push suspected findings on CT to the top of a radiologist's worklist, including incidental findings that matter in cancer care. | Aidoc | K261317, K253578, K251195 | Aidoc delivers clinical AI that empowers healthcare providers with faster, more accurate decision support. Ex… | AI in radiology, Aidoc CARE | aidoc.com | ||||
AI-Rad Companion Siemens Healthineers · first outside trace 2025 A family of reading algorithms for CT and MR, including organ contouring for radiotherapy and prostate MR reading. | Siemens Healthineers | K252548, K253057, K252608 | AI-Rad Companion automatically performs measurements and prepares results in the form of clinical images and… | AI in radiology, AI auto-contouring and adaptive planning | siemens-healthineers.com | ||||
Saige-Dx DeepHealth (RadNet) · first outside trace 2025 A mammography reading algorithm from RadNet's software arm, with triage and density products alongside it. | K253825, K254131, K251873 | none | AI in radiology | api.fda.gov | |||||
MammoScreen Therapixel · first outside trace 2024 A mammography reading algorithm that scores each breast and marks findings, with a separate density product. | Therapixel | K260714, K243685, K243679 | Therapixel is one of the leading French software companies specializing in artificial intelligence applied to… | AI in radiology | therapixel.com | ||||
SubtleMR and SubtlePET Subtle Medical · first outside trace 2024 Image enhancement software that lets MR and PET studies be acquired faster or at lower dose and reconstructed to diagnostic quality. | K254120, K254013, K243250 | Subtle Medical - Deep Learning boosts healthcare. Faster, Safer, Smarter. | CT, MRI and PET scanner manufacturing | subtlemedical.com | |||||
Annalise Enterprise CXR Annalise.ai (harrison.ai) · first outside trace 2023 A chest radiograph algorithm that reports many findings at once and triages the urgent ones, including masses and nodules. | K250831, K231384, K231767 | none | AI in radiology | api.fda.gov | |||||
AutoContour Radformation · first outside trace 2023 Automatic contouring sold alongside a set of plan checking tools, aimed at the time a physicist spends on routine work. | Radformation | K262452, K260509, K242729 | Radformation is a company dedicated to increasing the efficiency and decreasing the errors made in the radiat… | AI auto-contouring and adaptive planning | radformation.com | ||||
Contour ProtegeAI MIM Software (GE HealthCare) · first outside trace 2023 MIM's deep-learning contouring product, cleared separately from the rest of the suite. | MIM Software | K253270, K250035, K231765 | Provider of innovative solutions for Radiation Oncology, Nuclear Medicine, Radiology, Interventional Radiolog… | AI auto-contouring and adaptive planning | mimsoftware.com | ||||
ARIA Oncology Information System Varian (Siemens Healthineers) · first outside trace 2021 The oncology record and record-and-verify system that sits between a radiotherapy plan and the machine that delivers it, holding the prescription, the images, the schedule and the delivered dose. | Varian | K242463, K230699, K221408 | Legacy ARIA OIS supports oncology EMR workflows, clinical information management, and chemotherapy and radiat… | Oncology information and record-and-verify systems | varian.com | ||||
Genius AI Detection Hologic · first outside trace 2020 Hologic's detection algorithm for its own tomosynthesis systems, marking lesions and ranking cases for the reader. | Hologic | K243341, K230096, K221449 | Hologic develops diagnostics, surgical, and medical imaging technologies designed to advance women's health.… | AI in radiology | hologic.com | ||||
Tempus xT Tempus AI · first outside trace 2019 A sequencing panel and the interpretation platform Tempus reports it through, sold alongside its real-world data and trial-matching products. | Tempus AI | K253699, K241868, K250119 | none | Comprehensive genomic profiling, Cancer variant knowledgebases and molecular tumour boards | api.fda.gov | ||||
MOSAIQ Oncology Information System Elekta · first outside trace 2018 Elekta's oncology information system, the other half of the record-and-verify duopoly in radiotherapy departments, covering scheduling, prescription, delivery records and medical oncology. | Elekta | K223229, K203172, K183034 | Elekta MOSAIQ 3 | Oncology information and record-and-verify systems | elekta.com | ||||
Oncomine Dx Target Test Thermo Fisher Scientific · first outside trace 2025 An approved targeted sequencing test with companion diagnostic claims, run on the Ion Torrent platform in hospital laboratories rather than sent away. | Thermo Fisher Scientific | P240040/S005, P240040/S006, P160045/S052 | Discover Thermo Fisher Scientific's diagnostic solutions for solid tumor biomarker testing, powered by Ion To… | Comprehensive genomic profiling | thermofisher.com | ||||
Syngo Carbon Siemens Healthineers · first outside trace 2025 Siemens Healthineers' enterprise imaging and reading platform, the reporting environment around its scanners. | Siemens Healthineers | K254184, K253689, K251528 | Syngo Carbon gives rise to knowledge by providing a highly efficient, high quality and optimized clinical env… | CT, MRI and PET scanner manufacturing | siemens-healthineers.com | ||||
MIM Maestro MIM Software (GE HealthCare) · first outside trace 2024 Contouring, registration and dosimetry software used across radiation oncology and nuclear medicine, including dosimetry for radioligand therapy. | MIM Software | K253270, K251883, K250035 | Intuitive vendor-neutral Radiation Oncology and Radiation Therapy software designed to expedite treatment pla… | Radiotherapy treatment planning and QA software, AI auto-contouring and adaptive planning | mimsoftware.com | ||||
Philips IntelliSite Pathology Solution Philips · first outside trace 2024 A whole-slide scanning and viewing system for histopathology, the first such system cleared in the United States for primary diagnosis. | Philips | K243871, K242848, K241871 | Philips Healthcare Informatics solutions provide efficient workflows and clinical insights to help you delive… | Digital pathology & AI, Histopathology & immunohistochemistry | philips.co.uk |
(showing the first 30)
Looked for and not recorded
A product whose own site blocks automated readers, a company that has wound down, a laboratory test whose classifier is not software anyone can obtain, or something that belongs on another page. Each is on record so the gap is a decision, not an oversight.
- Oracle Health Oncology (Cerner) Every Oracle page answered the fetch with a firewall block, so not even the company's own words could be read and cited.
- navify Tumor Board and navify Mutation Profiler (Roche) Roche's product pages answered the fetch with a block page, so nothing could be quoted or verified.
- Mia (Kheiron Medical Technologies) The company's site answered the fetch with a block page and no FDA clearance is recorded under its name; nothing could be verified.
- Mendel.ai The site did not resolve at the time of the fetch.
- iQemo The site did not resolve at the time of the fetch; the NHS chemotherapy prescribing system could not be verified.
- Somerset Cancer Register No stable public product page was found that a fetch could cite.
- OpenClinica Already on /open-source/: its community edition is open source, so it belongs on that map rather than this one.
- Syapse The site now serves only a notice that it has moved, so no current description could be read.
- Deep 6 AI The site did not resolve at the time of the fetch.
- Fujifilm CAD EYE No Fujifilm product page for it returned a page at the time of the fetch.
- Elekta METRIQ Elekta publishes no current product page for its cancer registry software; only tag and article pages were found.
- Kaiku Health The product's own site no longer serves a page after the acquisition by Elekta.
- Oncotype DX, MammaPrint, Signatera, Galleri, Cologuard, BRACAnalysis CDx Laboratory tests whose classifier is proprietary rather than software a reader can obtain or run; the assay approvals belong on the test pages, not on a software map.
- Epic Beaker, Clinisys, Sunquest General laboratory information systems rather than oncology software; recorded here only as context for the pathology platforms.
- IBM Watson for Oncology Withdrawn from the market; the evaluations that exist describe a product no one can now buy, so it is left to the literature rather than given a row.
- ViewRay MRIdian The company wound down in 2024 and its product pages are gone, so nothing current could be fetched.
- Open-source projects of every kind Out of scope by design: they are mapped in full on /open-source/, which this page links to rather than duplicating.
Method. The list of products is hand-curated in scripts/software-curated.ts (one record per product, with its category, its vendor, the page to fetch and the queries to run). scripts/fetch-software.ts then fetches three services and writes src/data/software.ts, which is never edited by hand: the vendor's page for the claim in its own words, openFDA for the device databases, and Europe PMC for the literature. Of 136 records, 132 carry a claim read from the company's own page and 126 of those pages named the product in their text; where a page named only the company, the row says so on the claim. sourcing is computed from what came back, so no curator can promote a row by asserting it. Generated 2026-09-28; the same records are in the API as /api/v1/software.json.
Two honest limits. First, a clearance is a regulatory fact and not a clinical one: the FDA database says a device was cleared, never that it works well, and a 510(k) in particular says only that it resembles something already on the market. Second, a paper that names a product is evidence that the product reached the published record and that someone used or examined it. It is not evidence that the result was good, and some of these papers use the product rather than test it; read the paper. Where the literature check found nothing, that may mean the product has not been studied, or only that its name is too common to search for safely.
Missing a product, or a source we should have found? Suggest an edit. A company may send a link to a regulator's record, a published evaluation or a public framework listing, and the row will move from its own account to independently sourced on the next run. A link to its own website will not move it, which is the whole design.